JCA Meets AMNOG: German Benefit Assessments for Tarlatamab and Lurbinectedin Published
The German Federal Joint Committee (G-BA) has recently published its benefit assessments for tarlatamab and lurbinectedin, the second and third […]
October 7, 2026
Laurence Lapauw
I am motivated to contribute to translation of scientific evidence into clear key messages, which may be implemented to improve
